Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1451
Rollins
ROL
$16.7B
| $295K | ﹤0.01% |
7,060
-1,245,927
| -99% | -$63.7M |
2025 Q1
5 quarters
|
|
1452
Graham Holdings Company
GHC
$4.87B
| $294K | ﹤0.01% |
258
-12
| -4% | -$13.5K |
2013 Q2
52 quarters
|
|
1453
Criteo S.A.
CRTO
$718M
| $292K | ﹤0.01% |
16,000
| – | – |
2023 Q1
13 quarters
|
|
1454
PG&E
PCG
$39.6B
| $291K | ﹤0.01% |
17,309
+8,093
| +88% | +$136K |
2022 Q3
15 quarters
|
|
1455
Universal Display
OLED
$3.78B
| $291K | ﹤0.01% |
3,359
+1,154
| +52% | +$107K |
2018 Q4
30 quarters
|
|
1456
StandardAero Inc
SARO
$7.74B
| $288K | ﹤0.01% |
9,619
-565,265
| -98% | -$14.9M |
2024 Q4
6 quarters
|
|
1457
Monster Beverage
MNST
$92.7B
| $287K | ﹤0.01% |
5,968
-5,654
| -49% | -$238K |
2013 Q2
52 quarters
|
|
1458
First Mid Bancshares
FMBH
$1.34B
| $286K | ﹤0.01% |
5,953
+2,919
| +96% | +$129K |
2024 Q3
7 quarters
|
|
1459
Option Care Health
OPCH
$4.77B
| $283K | ﹤0.01% |
13,517
-338
| -2% | -$7.86K |
2021 Q3
19 quarters
|
|
1460
Maximus
MMS
$3.34B
| $282K | ﹤0.01% |
5,239
-604,653
| -99% | -$37.7M |
2013 Q2
52 quarters
|
|
1461
Apple Hospitality REIT
APLE
$4.37B
| $281K | ﹤0.01% |
+16,717
| New | +$239K |
2026 Q2
0 quarters
|
|
1462
Terreno Realty
TRNO
$7.14B
| $281K | ﹤0.01% |
4,336
+95
| +2% | +$6.21K |
2025 Q4
2 quarters
|
|
1463
Sabra Healthcare REIT
SBRA
$5.04B
| $281K | ﹤0.01% |
14,386
-996
| -6% | -$19.8K |
2016 Q3
39 quarters
|
|
1464
Brighthouse Financial
BHF
$2.53B
| $280K | ﹤0.01% |
4,418
+1,998
| +83% | +$124K |
2017 Q4
34 quarters
|
|
1465
Sonoco
SON
$4.94B
| $279K | ﹤0.01% |
4,948
-2,892
| -37% | -$148K |
2013 Q2
52 quarters
|
|
1466
Larimar Therapeutics
LRMR
$257M
| $277K | ﹤0.01% |
90,850
+29,500
| +48% | +$117K |
2025 Q2
4 quarters
|
|
1467
Nu Skin
NUS
$226M
| $276K | ﹤0.01% |
52,313
-12,909
| -20% | -$82.5K |
2013 Q2
52 quarters
|
|
1468
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $275K | ﹤0.01% |
3,441
-87,150
| -96% | -$6.97M |
2024 Q4
6 quarters
|
|
1469
Kyverna Therapeutics
KYTX
$351M
| $274K | ﹤0.01% |
30,705
+10,000
| +48% | +$88.8K |
2024 Q2
8 quarters
|
|
1470
Air Products & Chemicals
APD
$70.5B
| $273K | ﹤0.01% |
931
-3
| -0.3% | -$873 |
2013 Q2
52 quarters
|
|
1471
ADT
ADT
$7.2B
| $271K | ﹤0.01% |
41,675
+710
| +2% | +$4.87K |
2024 Q3
7 quarters
|
|
1472
Grupo Aeromexico SAB de CV
AERO
$2.32B
| $270K | ﹤0.01% |
15,000
+5,000
| +50% | +$80.3K |
2025 Q4
2 quarters
|
|
1473
Wealthfront Corp
WLTH
$1.6B
| $268K | ﹤0.01% |
30,000
-210,000
| -88% | -$2.19M |
2025 Q4
2 quarters
|
|
1474
PACCAR
PCAR
$53.7B
| $264K | ﹤0.01% |
2,200
-1,375
| -38% | -$162K |
2013 Q2
52 quarters
|
|
1475
Enterprise Financial Services Corp
EFSC
$2.21B
| $264K | ﹤0.01% |
4,007
+707
| +21% | +$42.5K |
2013 Q2
52 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.